Literature DB >> 2057662

Using databases to evaluate therapy.

M A Hlatky1.   

Abstract

Clinical and administrative databases are increasingly used for clinical research. Descriptive studies and analyses of prognostic factors are established research uses of databases, but using them to compare therapies remains controversial. Such comparisons may be possible when a validated model of prognosis can account for the effect of clinically recognized variables on outcome. Models meeting these criteria have been developed using the Duke Cardiovascular Disease Database. They were applied to compare medical therapy to surgical therapy for coronary artery disease. Predictions from these models agreed well with the results of the three major randomized trials of bypass surgery versus medical therapy. These findings indicate that when data is reliable and understanding of factors affecting prognosis is good, researchers can use statistical techniques to minimize the bias due to non-random treatment assignment. Carefully performed analyses of observational clinical data can complement and extend randomized studies.

Entities:  

Mesh:

Year:  1991        PMID: 2057662     DOI: 10.1002/sim.4780100415

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  3 in total

1.  The development and implementation of a computerized database for clinical research in minimal access surgery. An international pilot study.

Authors:  D W Birch; A Park; M Bailey; W Witzke; D Witzke; J Hoskins
Journal:  Surg Endosc       Date:  2001-07-05       Impact factor: 4.584

2.  Computer-assisted test interpretation: considerations in patient care.

Authors:  S D Hillson; D P Connelly
Journal:  J Med Syst       Date:  1992-10       Impact factor: 4.460

3.  Imaging-based observational databases for clinical problem solving: the role of informatics.

Authors:  Alex A T Bui; William Hsu; Corey Arnold; Suzie El-Saden; Denise R Aberle; Ricky K Taira
Journal:  J Am Med Inform Assoc       Date:  2013-06-17       Impact factor: 4.497

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.